The Ohio State University (OSU) Neuroscience Center provides support for studies ainned at analysis and treatment of neurological disorders with an emphasis on animal models. The Center is a collaborative effort of 43 neuroscientists (25 NINDS funded) from OSU and Nationwide Children's Hospital. The majority of these Pis work on aspects of nervous system disorders with four major focus areas being motoneuron disease, neuromuscular disease, CNS and PNS injury, and brain tumors. These Pis span numerous departments, centers, and institutes at OSU that support basic and translational neuroscience research making the Center a nucleus of neuroscience activity on campus. Center priorities align with and can leverage the Neuroscience Signature Program at OSU, a multi-million dollar effort supporting Neuroscience as one of five growth areas on campus. In addition, the Center aligns with the newly granted Clinical and Translational Science Award to the OSU Medical Center. To support the development, characterization and analysis of nervous system disease models, this proposal supports 5 research Cores. Core A (Administrative) will oversee the OSU Neuroscience Center. Core B (Genetics) will support the development of transgenic/knockout mice and the use of zebrafish with an emphasis on traditional and novel genetic approaches. In addition this Core will support a Genome Manipulation Facility focusing on zinc-finger nuclease and BAC recombineering techniques for the generation of new animal models. Core C (CNS/PNS Injury and Rodent Behavior) will provide the equipment and technical expertise to generate injury models and to analyze behavioral deficits associated with these models. Core D (Physiology) will provide equipment and technical assistance for both electrophysiology and muscle physiology to analyze these models. Core E (Imaging) will support both Confocal and MRI imaging with reduced costs and technical assistance. Core F (Xenograft) will provide equipment and technical assistance to generate mouse models of brain tumors. These unique Cores will provide Pis with access to centralized equipment and technical expertise unavailable in any single lab, thus substantially enhancing neuroscience research on the OSU campus.
This award will fund Cores that support the development, characterization, and analysis of animal models of neurological diseases and injury. As such the goals of the Center are directly inline with the NINDS mission.
|Welker, Alessandra M; Jaros, Brian D; Puduvalli, Vinay K et al. (2016) Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity. Dis Model Mech 9:199-210|
|Yoo, Ji Young; Jaime-Ramirez, Alena Cristina; Bolyard, Chelsea et al. (2016) Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy. Clin Cancer Res 22:5265-5276|
|Borniger, Jeremy C; CissÃ©, Yasmine M; Cantemir-Stone, Carmen Z et al. (2016) Behavioral abnormalities in mice lacking mesenchyme-specific Pten. Behav Brain Res 304:80-5|
|Green, Jill A; Schmid, Cullen L; Bley, Elizabeth et al. (2016) Recruitment of Î²-Arrestin into Neuronal Cilia Modulates Somatostatin Receptor Subtype 3 Ciliary Localization. Mol Cell Biol 36:223-35|
|Ru, Peng; Hu, Peng; Geng, Feng et al. (2016) Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth. Cell Rep 16:1527-35|
|Hansen, Katelin F; Sakamoto, Kensuke; Aten, Sydney et al. (2016) Targeted deletion of miR-132/-212 impairs memory and alters the hippocampal transcriptome. Learn Mem 23:61-71|
|Church, Jamie S; Kigerl, Kristina A; Lerch, Jessica K et al. (2016) TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord. J Neurosci 36:6352-64|
|Lowe, Jeovanna; Floyd, Kyle T; Rastogi, Neha et al. (2016) Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice. J Neuromuscul Dis 3:395-404|
|Gygli, Patrick E; Chang, Joshua C; Gokozan, Hamza N et al. (2016) Cyclin A2 promotes DNA repair in the brain during both development and aging. Aging (Albany NY) 8:1540-70|
|Saad, Nancy S; Floyd, Kyle; Ahmed, Amany A E et al. (2016) The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities. PLoS One 11:e0153694|
Showing the most recent 10 out of 210 publications